Hip Bursitis: Causes, Symptoms, and Treatment Options

Hip Bursitis: Causes, Symptoms, and Treatment Options

Hip bursitis, a common yet often underdiagnosed musculoskeletal condition, presents a significant clinical challenge within orthopedic practice. Characterized by inflammation of the bursae surrounding the hip joint, this pathology can lead to substantial pain and functional impairment. Understanding the etiology, clinical presentation, and evolving treatment modalities of hip bursitis is essential for orthopedic surgeons, fellows, and residents aiming to optimize patient outcomes in both acute and chronic settings.

Overview and Clinical Significance

Hip bursitis primarily involves inflammation of the trochanteric bursa, although inflammation of the iliopsoas or ischial bursae can also occur. The condition is frequently encountered in outpatient orthopedic clinics and can mimic other intra-articular hip pathologies, complicating diagnosis and management. Given the increasing prevalence of hip pain in aging populations and active individuals, hip bursitis remains a pertinent topic in contemporary orthopedic care.

Causes of Hip Bursitis

Hip bursitis arises from a multifactorial etiology, often involving mechanical, inflammatory, and systemic factors:

• Repetitive Microtrauma: Overuse injuries from activities such as running, cycling, or prolonged standing can cause repetitive friction and irritation of the bursa.
• Direct Trauma: Acute injury to the lateral hip, including falls or blunt force, can precipitate bursitis.
• Biomechanical Abnormalities: Leg length discrepancy, altered gait mechanics, and hip osteoarthritis contribute to abnormal stress on the bursae.
• Systemic Inflammatory Conditions: Rheumatoid arthritis, gout, and other inflammatory arthropathies may predispose patients to bursitis.
• Iatrogenic Causes: Postoperative changes or corticosteroid injections can sometimes lead to secondary bursitis.
• Age-Related Degeneration: Degenerative changes in periarticular soft tissues increase susceptibility in older adults.

Symptoms and Clinical Presentation

The hallmark symptom of hip bursitis is lateral hip pain, often localized over the greater trochanter. Key clinical features include:

• Pain Characteristics:
• Sharp or burning pain exacerbated by lying on the affected side.
• Pain during activities such as climbing stairs, prolonged walking, or standing.
• Physical Examination Findings:
• Tenderness over the greater trochanter.
• Pain reproduced by resisted hip abduction or external rotation.
• Possible swelling or erythema in acute cases.
• Functional Limitations:
• Reduced range of motion due to pain.
• Gait disturbances secondary to discomfort.

Differential diagnosis should consider trochanteric tendinopathy, lumbar radiculopathy, hip osteoarthritis, and referred pain from the spine.

Diagnostic Approaches

Accurate diagnosis relies on a combination of clinical evaluation and imaging modalities:

• Clinical Assessment: Detailed history and physical examination remain paramount.
• Imaging:
• Ultrasound: Useful for detecting bursal fluid accumulation and guiding injections.
• MRI: Provides detailed visualization of bursal inflammation, adjacent tendinopathy, and exclusion of intra-articular pathology.
• Laboratory Tests: Indicated when systemic inflammatory or infectious causes are suspected.

Treatment Options

Management of hip bursitis is typically conservative, with surgical intervention reserved for refractory cases.

Conservative Management

• Activity Modification: Avoidance of aggravating activities to reduce mechanical stress.
• Pharmacologic Therapy:
• NSAIDs for pain and inflammation control.
• Analgesics as adjunctive therapy.
• Physical Therapy:
• Focused on stretching and strengthening hip abductors and external rotators.
• Gait retraining and biomechanical correction.
• Injection Therapy:
• Corticosteroid injections provide rapid symptom relief.
• Emerging use of platelet-rich plasma (PRP) for refractory cases.

Surgical Interventions

Indicated in patients with persistent symptoms despite exhaustive conservative treatment:

• Bursectomy: Open or endoscopic removal of the inflamed bursa.
• Iliotibial Band Release: Addressing tightness contributing to bursal irritation.
• Tendon Repair: In cases with concomitant gluteal tendon tears.

Current Trends in Hip Bursitis Management

Recent literature emphasizes a multimodal approach integrating advanced imaging and minimally invasive techniques. The role of ultrasound-guided interventions has expanded, improving diagnostic accuracy and therapeutic precision. Additionally, there is growing recognition of the interplay between hip bursitis and gluteal tendinopathy, prompting combined treatment strategies.

Innovations Impacting Diagnosis and Treatment

• Ultrasound-Guided Procedures: Enhanced accuracy in corticosteroid and PRP injections, reducing complications.
• Biologic Therapies: PRP and stem cell injections are under investigation for their potential to promote tissue healing and reduce inflammation.
• Endoscopic Surgery: Minimally invasive bursectomy and iliotibial band release offer reduced morbidity and faster recovery compared to open techniques.
• Wearable Technology: Gait analysis devices assist in identifying biomechanical contributors to bursitis, facilitating personalized rehabilitation.

Viewpoints and Controversies

Debate persists regarding the optimal timing and choice of injection therapies, particularly the long-term efficacy and safety of corticosteroids versus biologics. The role of surgery remains controversial, with some advocating for early intervention in refractory cases, while others emphasize prolonged conservative management. Additionally, the differentiation between trochanteric bursitis and gluteal tendinopathy continues to challenge clinicians, influencing treatment decisions.

Current Challenges in Clinical Practice

• Diagnostic Ambiguity: Overlapping symptoms with other hip pathologies complicate diagnosis.
• Treatment Resistance: A subset of patients exhibit persistent symptoms despite standard therapies.
• Limited High-Quality Evidence: Few randomized controlled trials guide management, particularly regarding biologic treatments.
• Patient Compliance: Activity modification and rehabilitation adherence can be difficult to maintain.

Potential Solutions and Best Practices

• Multidisciplinary Approach: Collaboration between orthopedic surgeons, physiatrists, and physical therapists enhances comprehensive care.
• Standardized Diagnostic Protocols: Incorporating clinical criteria with imaging to improve diagnostic accuracy.
• Patient Education: Emphasizing the importance of adherence to rehabilitation and activity modification.
• Research Initiatives: Encouraging clinical trials to evaluate emerging therapies and refine treatment algorithms.

Impact on Patient Care

Effective management of hip bursitis significantly improves patient quality of life by alleviating pain, restoring function, and preventing chronic disability. Early diagnosis and tailored treatment reduce healthcare utilization and enhance patient satisfaction. Addressing biomechanical contributors and comorbidities optimizes long-term outcomes and minimizes recurrence.

Future Outlook

Advancements in imaging and biologic therapies are poised to transform hip bursitis management. Personalized medicine approaches, integrating genetic and biomechanical profiling, may enable targeted interventions. The expansion of minimally invasive surgical techniques will likely reduce recovery times and improve functional results. Ongoing research into the pathophysiology of bursitis and its relationship with tendinopathy will refine diagnostic criteria and therapeutic strategies, ultimately elevating standards of orthopedic care.

Key Takeaways

• Hip bursitis is a prevalent cause of lateral hip pain with multifactorial etiology requiring thorough clinical and imaging evaluation.
• Conservative management remains the cornerstone of treatment, with corticosteroid injections and physical therapy playing pivotal roles.
• Emerging biologic therapies and minimally invasive surgical techniques offer promising alternatives for refractory cases.
• Diagnostic challenges and treatment controversies necessitate a multidisciplinary, evidence-based approach.
• Future developments in personalized medicine and advanced therapeutics hold potential to enhance patient outcomes and redefine management paradigms.

Hip bursitis exemplifies the complexity of periarticular soft tissue disorders in orthopedics, demanding continual refinement of diagnostic acumen and therapeutic innovation to meet evolving patient needs.

Last Updated on January 26, 2026 by OrthoNet AI